Oliver Rosen
2020
In 2020, Oliver Rosen earned a total compensation of $1.1M as Chief Medical Officer at SQZ Biotechnologies Co, a 26% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $148,019 |
|---|---|
| Option Awards | $502,334 |
| Salary | $400,722 |
| Other | $8,550 |
| Total | $1,059,625 |
Rosen received $502.3K in option awards, accounting for 47% of the total pay in 2020.
Rosen also received $148K in non-equity incentive plan, $400.7K in salary and $8.6K in other compensation.
Rankings
In 2020, Oliver Rosen's compensation ranked 8,387th out of 13,090 executives tracked by ExecPay. In other words, Rosen earned more than 35.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,387 out of 13,090 | 36th |
Division Manufacturing | 3,564 out of 5,621 | 37th |
Major group Chemicals And Allied Products | 1,443 out of 2,254 | 36th |
Industry group Drugs | 1,255 out of 1,954 | 36th |
Industry Biological Products, Except Diagnostic Substances | 298 out of 411 | 28th |
Source: SEC filing on April 26, 2021.
Rosen's colleagues
We found four more compensation records of executives who worked with Oliver Rosen at SQZ Biotechnologies Co in 2020.